Story

SpaceX Stock Nears IPO Price, Testing Investor Confidence and Market for New Listings

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20262 min read
SpaceX Stock Nears IPO Price, Testing Investor Confidence and Market for New Listings

Summary

Shares of Elon Musk's SpaceX are trading just above their initial public offering price, raising concerns about lofty tech valuations and potentially complicating the plans for other major companies eyeing the public markets.

Text size
Background

Shares of SpaceX are hovering near their initial public offering price after a period of volatile trading, turning one of the year's most anticipated market debuts into a critical test of investor confidence. The stock closed Tuesday at $136.08, down 2.2% and just above its $135 offer price, marking its lowest closing level since its June 12 listing.

A Psychological Test for the Market

After debuting, Elon Musk's aerospace and technology company initially soared, at one point reaching a valuation well above $2 trillion. However, the stock has since slipped from its $150 opening price, reflecting broader concerns about high valuations in the technology sector.

A drop below the IPO price would represent a significant "psychological blow," according to Matthew Maley, chief market strategist at Miller Tabak. Maley told Reuters that such a move could fuel a narrative that the stock's initial surge was driven by "fluff, on speculation, on froth, and not on real fundamentals."

Implications for Future IPOs

SpaceX's performance is being closely monitored by other private companies, such as OpenAI and Anthropic, that are reportedly considering public listings. Greg Halter, director of research at Carnegie Investment Counsel, noted that companies and their investment banks are watching carefully, as "no one wants an IPO to flop."

Sample IUX Markets – In-articleAd

Halter suggested that sustained weakness in SpaceX could lead other firms to pull their offerings rather than accept lower valuations. However, Ryan Lee, senior vice president at Direxion, offered a different perspective, arguing that the intense competition and capital needs in fields like AI might push companies to accelerate their IPO plans to get ahead of rivals.

Price Discovery and Retail Risk

Analysts caution that post-IPO volatility is a normal part of the market's price discovery process. Gabriel Shahin, CEO at Falcon Wealth Planning, described a potential dip below $135 as "normal, albeit painful" market mechanics, particularly as early investors and employees begin to sell shares after lockup periods expire.

This volatility could disproportionately affect retail investors, who received an estimated 20% of the IPO allocation. Shahin warned that many novice investors approached SpaceX with a "'meme stock' mentality," and losses could fuel perceptions that markets are tilted in favor of insiders. The company's first earnings report is expected to be the next major test for the stock.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST